965
Views
13
CrossRef citations to date
0
Altmetric
Hematology

Newly diagnosed iron deficiency anemia and subsequent autoimmune disease: a matched cohort study in Taiwan

, , , , &
Pages 985-992 | Received 13 Nov 2019, Accepted 25 Mar 2020, Published online: 14 Apr 2020
 

Abstract

Objective

To explore whether newly diagnosed iron deficiency anemia (IDA) is associated with subsequent systemic autoimmune disease onset.

Methods

The study identified 22,440 patients who received a diagnosis of IDA between 2000 and 2012 from a random sample of 1 million people from Taiwans National Health Insurance Research Database. The patients with IDA were randomly matched with 89,528 patients with no IDA by age, gender, and index year. We followed the 2 groups until systemic autoimmune disease onset. Cox proportional hazards analysis was used to determine autoimmune disease risk by age, gender, and comorbidities, in terms of hazard ratios (HRs) and 95% confidence intervals (CIs).

Results

Adjusted HR (95% CI) of autoimmune disease in the IDA group was 2.37 (1.92–2.92) compared with the non-IDA group. The subgroup analysis indicated that a patient with IDA had a significantly greater risk of autoimmune disease if they were female or had the comorbidities of hypertension, hyperlipidemia, cancer, allergic rhinitis, urticaria, chronic obstructive pulmonary disease, or chronic liver disease. The autoimmune disease was significantly more likely to occur within 2 years after a new diagnosis of IDA.

Conclusions

IDA significantly increases autoimmune disease risk, particularly in female patients and patients with certain comorbidities. Clinicians should conduct further clinical evaluations and laboratory tests of autoimmune disease in patients with IDA.

Plain Language Summary

Little is known about the relationship between iron deficiency and autoimmune disease. By using a national-level database in Taiwan, we noted a meaningful association between iron deficiency anemia (IDA) and later autoimmune disease development. Our study extends the known disease range and recommends that physicians be alert for the occurrence of autoimmune disease after an IDA diagnosis. The subgroup analysis indicated that, among patients with IDA, female patients and patients with the simultaneous chronic diseases of allergic rhinitis, urticaria, cancer, chronic obstructive pulmonary disease (COPD), hyperlipidemia, or hypertension had a significantly higher risk of autoimmune disease. The risk of autoimmune disease was considerably higher within the 2 years after an IDA diagnosis.

Transparency

Declaration of funding

This work was supported by grants from the Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133004]; China Medical University Hospital; and Academia Sinica Stroke Biosignature Project [BM10701010021]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Declaration of financial/other relationships

The authors and peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Author contributions

Study conception and design: RC, KAC, YHC, YMH, JCCW; acquisition of data: MCL; analysis and interpretation of data: KAC, RC, YMH, MCL, JCCW; writing (original draft preparation): RC, KAC, YMH; writing (review and editing): YMH, JCCW.

Acknowledgements

This manuscript was edited by Wallace Academic Editing.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.